Poland-Nowy S?cz: Antineoplastic and immunomodulating agents

Agency: TED
State:
Level of Government: State & Local
Category:
  • 68 - Chemicals and Chemical Products
Opps ID: NBD00003307742660401
Posted Date: Sep 30, 2017
Due Date: Nov 7, 2017
Solicitation No: 384622-2017
Source: Members Only
30/09/2017 S188 - - Supplies - Contract notice - Open procedure

Poland-Nowy S?cz: Antineoplastic and immunomodulating agents

2017/S 188-384622

Contract notice

Supplies

Directive 2014/24/EU

Section I: Contracting authority

I.1) Name and addresses
Szpital Specjalistyczny im. J?drzeja ?niadeckiego
ul. Mly?ska 10
Nowy S?cz
33-300
Poland
Contact person: zespol ds. zamowie? publiczych
Telephone: +48 184436635
E-mail: zamowieniapubliczne@szpitalnowysacz.pl
Fax: +48 184436635
NUTS code: PL218

Internet address(es):

Main address: www.szpitalnowysacz.pl

I.2) Joint procurement
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at: www.szpitalnowysacz.pl
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted to the abovementioned address
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health

Section II: Object

II.1) Scope of the procurement
II.1.1) Title:

Dostawa lekow przeciwnowotworowych.

Reference number: DA271-56/17
II.1.2) Main CPV code
33652000
II.1.3) Type of contract
Supplies
II.1.4) Short description:

Przedmiot zamowienia jest podzielony na 25 cz??ci ? kod CPV- 33652000-5

Zadanie nr 1 ? Leki przeciwnowotworowe

Zadanie nr 2- Leki przeciwnowotworowe

Zadanie nr 3- Filgasterim

Zadanie nr 4- Leki przeciwnowotworowe

Zadanie nr 5- Interferon alfa

Zadanie nr 6- Leki przeciwnowotworowe

Zadanie nr 7- Leki przeciwnowotworowe

Zadanie nr 8- Rituximab

Zadanie nr 9- Pertuzumab i Trastuzumab

Zadanie nr 10- Olaparyb

Zadanie nr 11- Lipegfilgrastym

Zadanie nr 12- Leki przeciwnowotworowe

Zadanie nr 13- Doxorubicinum lizosomalna pegylowana

Zadanie nr 14- Vinorelbin

Zadanie nr 15- Temodal

Zadanie nr 16- Anagrelidum

Zadanie nr 17- Lapatinib

Zadanie nr 18- Bendamustine

Zadanie nr 19- Cytarabina liposomalna

Zadanie nr 20- Bortezomib

Zadanie nr 21- Lenalidomid

Zadanie nr 22- Abiraterone acetate

Zadanie nr 23- Gefitinib

Zadanie nr 24- Imatinib

Zadanie nr 25- Afatynib.

II.1.5) Estimated total value
Value excluding VAT: 9 780 786.39 PLN
II.1.6) Information about lots
This contract is divided into lots: yes
Tenders may be submitted for all lots
II.2) Description
II.2.1) Title:

Leki przeciwnowotworowe

Lot No: 1
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Leki przeciwnowotworowe.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 515 957.49 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Leki przeciwnowotworowe

Lot No: 2
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Leki przeciwnowotworowe.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 461 450.10 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Filgasterim

Lot No: 3
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Filgasterim.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 2 275.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Leki przeciwnowotworowe

Lot No: 4
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Leki przeciwnowotworowe.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 158 060.25 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Interferon alfa

Lot No: 5
II.2.2) Additional CPV code(s)
33690000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Interferon alfa.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 9 496.20 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Leki przeciwnowotworowe

Lot No: 6
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Leki przeciwnowotworowe.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 1 217 823.56 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Leki przeciwnowotworowe

Lot No: 7
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Leki przeciwnowotworowe.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 392 013.50 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Rituximab

Lot No: 8
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Rituximab.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 1 281 590.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Pertuzumab i Trastuzumab

Lot No: 9
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Pertuzumab i Trastuzumab.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 2 711 451.50 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Olaparyb

Lot No: 10
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Olaparyb.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 254 664.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Lipegfilgrastym

Lot No: 11
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Lipegfilgrastym.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 36 400.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Leki przeciwnowotworowe

Lot No: 12
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Leki przeciwnowotworowe.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 274 300.20 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Doxorubinum lizosomalna pegylowana

Lot No: 13
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Doxorubinum lizosomalna pegylowana.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 231 414.40 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Vinorelbin

Lot No: 14
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Vinorelbin.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 5 261.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Temodal

Lot No: 15
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Temodal.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 40 575.60 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Anagrelidum

Lot No: 16
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Anagrelidum.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 237 195.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Lapatinib

Lot No: 17
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Lapatinib.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 44 121.24 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Bendamustine

Lot No: 18
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Bendamustine.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 73 387.50 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Cytarabina liposomalna

Lot No: 19
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Cytarabina liposomalna.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 54 229.50 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Bortezomib

Lot No: 20
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Bortezomib.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 76 398.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Lenalidomid

Lot No: 21
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Lenalidomid.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 1 016 569.11 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Abiraterone acetate

Lot No: 22
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Abiraterone acetate.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 333 850.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Gefitinib

Lot No: 23
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Gefitinib.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 96 480.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Imatinib

Lot No: 24
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Imatinib.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 1 706.88 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information
II.2) Description
II.2.1) Title:

Afatynib

Lot No: 25
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
Main site or place of performance:

Siedziba Zamawiaj?cego- apteka szpitalna.

II.2.4) Description of the procurement:

Afatynib.

II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT: 206 759.36 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.12) Information about electronic catalogues
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14) Additional information

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation
III.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:

Warunek ten zostanie spelniony, je?eli Wykonawca wyka?e, ?e posiada dokumenty potwierdzaj?ce posiadanie uprawnie? do wykonywania okre?lonej dzialalno?ci lub czynno?ci tj. koncesj?, zezwolenie, lub licencje na prowadzenie hurtowni farmaceutycznej w zakresie obrotu produktami leczniczymi lub w przypadku wykonawcy prowadz?cego sklad konsygnacyjny- zezwolenie na jego prowadzenie

Je?eli wykonawca ma siedzib? lub miejsce zamieszkania poza terytorium Rzeczypospolitej Polskiej zamiast dokumentow, o ktorych mowa w pkt 3:

1) lit. d- sklada informacj? z odpowiedniego rejestru albo, w przypadku braku takiego rejestru, inny rownowa?ny dokument wydany przez wla?ciwy organ s?dowy lub administracyjny kraju w ktorym Wykonawca ma siedzib? lub miejsce zamieszkania lub miejsce zamieszkania ma osoba, ktorej dotyczy informacja albo dokument w zakresie okre?lonym w art. 24 ust 1 pkt. 13,14 i 21 oraz ust. 5 pkt.5 i 6 ustawy,

2) lit. a- c ? sklada dokument lub dokumenty wystawione w kraju, w ktorym ma siedzib? lub miejsce zamieszkania, potwierdzaj?ce odpowiednio, ?e:

a) nie zalega z oplaceniem podatkow, oplat, skladek na ubezpieczenie spoleczne lub zdrowotne albo ?e zawarl porozumienie z wla?ciwym organem w sprawie splat tych nale?no?ci wraz z ewentualnymi odsetkami lub grzywnami, w szczegolno?ci uzyskal przewidziane prawem zwolnienie, odroczenie lub rozlo?enie na raty zaleglych platno?ci lub wstrzymanie w calo?ci wykonania decyzji wla?ciwego organu,

b) nie otwarto jego likwidacji ani nie ogloszono upadlo?ci,

Dokumenty, o ktorych mowa w pkt 17 ppkt 2) lit.a) i ppkt 1), powinny by? wystawione nie wcze?niej ni? 6 miesi?cy przed uplywem terminu skladania ofert albo wnioskow o dopuszczenie do udzialu w post?powaniu. Dokument, o ktorym mowa w pkt 17 ppkt 2) lit. b i c), powinien by? wystawiony nie wcze?niej ni? 3 miesi?ce przed uplywem tego terminu.

Je?eli w kraju w ktorym wykonawca ma siedzib? lub miejsce zamieszkania lub miejsce zamieszkania ma osoba, ktorej dokument dotyczy, nie wydaje si? dokumentow, o ktorych mowa w pkt 17 ppkt 1), zast?puje si? je dokumentem zawieraj?cym odpowiednio o?wiadczenie wykonawcy, ze wskazaniem osoby albo osob uprawnionych do jego reprezentacji, lub o?wiadczenie osoby, ktorej dokument mial dotyczy?, zlo?one przed notariuszem lub przed organem s?dowym, administracyjnym albo organem samorz?du zawodowego lub gospodarczego wla?ciwym ze wzgl?du na siedzib? lub miejsce zamieszkania wykonawcy lub miejsce zamieszkania tej osoby. Przepis pkt 17 pkt.2) stosuje si?.

W przypadku w?tpliwo?ci co do tre?ci dokumentu zlo?onego przez Wykonawc?, zamawiaj?cy mo?e zwroci? si? do wla?ciwych organow odpowiednio kraju, w ktorym wykonawca ma siedzib? lub miejsce zamieszkania ma osoba, ktorej dokument dotyczy, o udzielenie niezb?dnych informacji dotycz?cych tego dokumentu.

W przypadku wspolnego ubiegania si? o zamowienie przez wykonawcow, o?wiadczenie na Jednolitym Europejskim Dokumencie Zamowienia ? wg wzorow na zal?czniku nr 3 do SIWZ sklada ka?dy z wykonawcow wspolnie ubiegaj?cych si? o zamowienie. Dokumenty te potwierdzaj? spelnianie warunkow udzialu w oraz brak podstaw wykluczenia w zakresie, w ktorym ka?dy z wykonawcow wykazuje spelnianie warunkow udzialu w post?powaniu oraz brak podstaw wykluczenia.

III.1.2) Economic and financial standing
III.1.3) Technical and professional ability
III.1.5) Information about reserved contracts
III.2) Conditions related to the contract
III.2.2) Contract performance conditions:

Wykonawca, ktorego oferta zostanie wybrana jako najkorzystniejsza, zobowi?zany b?dzie

do zawarcia umowy w terminie okre?lonym przez zamawiaj?cego, nie krotszym ni? 10 dni od dnia przeslania zawiadomienia o wyborze oferty najkorzystniejszej za po?rednictwem drogi e-mail, z zastrze?eniem sytuacji okre?lonej w art. 94 ust. 2 pkt. 1) lit. a oraz pkt. 3) lit a ustawy PZP.

Je?eli wykonawca, ktorego oferta zostala wybrana jako najkorzystniejsza, b?dzie uchylal si?

od zawarcia umowy, zamawiaj?cy mo?e wybra? ofert? najkorzystniejsz? spo?rod pozostalych ofert, bez przeprowadzania ich ponownej oceny, chyba, ?e zachodz? przeslanki uniewa?nienia post?powania.

Ogolne warunki umowy istotne dla Zamawiaj?cego zawarte s? w zal?czniku nr 4 ? Projekt umowy.

Zamawiaj?cy przewiduje dokonanie zmian postanowie? zawartej umowy w stosunku do tre?ci oferty na podstawie ktorej dokonano wyboru Wykonawcy w przypadku zaistnienia okoliczno?ci, o ktorych mowa w art. 144.

III.2.3) Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
IV.1.4) Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6) Information about electronic auction
IV.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: no
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
IV.2.2) Time limit for receipt of tenders or requests to participate
Date: 07/11/2017
Local time: 11:00
IV.2.3) Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4) Languages in which tenders or requests to participate may be submitted:
Polish
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 2 (from the date stated for receipt of tender)
IV.2.7) Conditions for opening of tenders
Date: 07/11/2017
Local time: 11:15
Place:

Zespol ds. Zamowie? Publicznych, Szpital Specjalistyczny im. J?drzeja ?niadeckiego w Nowym S?czu, ul. Mly?ska 5.

Section VI: Complementary information

VI.1) Information about recurrence
This is a recurrent procurement: no
VI.2) Information about electronic workflows
VI.3) Additional information:

Warunkiem udzialu w post?powaniu o udzielenie zamowienia jest wniesienie wadium w prawidlowej wysoko?ci dla danej cz??ci, na ktor? Wykonawca sklada ofert?.

Calkowita kwota wadium wynosi: 95 790,00 PLN

W celu potwierdzenia braku podstaw do wykluczenia, Wykonawca w terminie 3 dni od dnia przekazania informacji, o ktorej mowa w art. 86 ust. 6 ustawy przekazuje Zamawiaj?cemu:

List? podmiotow nale??cych do tej samej grupy kapitalowej, wraz z o?wiadczeniem o przynale?no?ci b?d? braku przynale?no?ci do tej samej grupy kapitalowej ? wedlug wzoru na zal?czniku nr 5 do SIWZ.

Wykonawca, ktory polega na zdolno?ciach lub sytuacji innych podmiotow, musi udowodni? zamawiaj?cemu, ?e realizuj?c zamowienie, b?dzie dysponowal niezb?dnymi zasobami tych podmiotow, w szczegolno?ci przedstawiaj?c zobowi?zanie tych podmiotow do oddania mu do dyspozycji niezb?dnych zasobow na potrzeby realizacji zamowienia ? wg wzoru na zal?czniku nr 7 do SIWZ.

Inne.

1. Oferty wariantowe

Zamawiaj?cy nie dopuszcza mo?liwo?ci skladania ofert wariantowych.

2. Oferty cz??ciowe

Zamawiaj?cy nie dopuszcza skladania ofert cz??ciowych w ramach zadania.

3. Informacja o przewidywanych zamowieniach o ktorych mowa w art. 67 ust.1 pkt 6

Zamawiaj?cy nie przewiduje udzielania zamowie?, o ktorych mowa w art. 67 ust.1 pkt 7 Pzp

4. Aukcja elektroniczna

Zamawiaj?cy nie przewiduje wyboru oferty z zastosowaniem aukcji elektronicznej

5. Informacja o walutach obcych

Zamawiaj?cy nie dopuszcza mo?liwo?ci prowadzenia rozlicze? w innych walutach ni? PLN

6. Zwrot kosztow

Zamawiaj?cy nie przewiduje zwrotu kosztow udzialu w post?powaniu z zastrze?eniem wyj?tkow okre?lonych w ustawie Pzp.

7. Wymagania o ktorych mowa w art. 29 ust.4

Zamawiaj?cy nie precyzuje wymaga?, o ktorych mowa w art.29 ust.4 Pzp.

8. Odwrocona zasada oceny ofert

Zamawiaj?cy informuje, ?e stosownie do dyspozycji art. 24aa ustawy Prawo zamowie? publicznych najpierw dokona oceny ofert, a nast?pnie zbada, czy Wykonawca, ktorego oferta zostala oceniona jako najkorzystniejsza, nie podlega wykluczeniu oraz spelnia warunki udzialu w post?powaniu.

VI.4) Procedures for review
VI.4.1) Review body
Prezes Krajowej Izby Odwolawczej
ul. Post?pu 17A
Warszawa
02-676
Poland
Telephone: +48 224587801
Fax: +48 224587800

Internet address: http://www.uzp.gov.pl

VI.4.2) Body responsible for mediation procedures
VI.4.3) Review procedure
VI.4.4) Service from which information about the review procedure may be obtained
Urz?d Zamowie? Publicznych ? Departament Odwola?
ul. Post?pu 17A
Warszawa
02-676
Poland
Telephone: +48 224587801
E-mail: odwolania@uzp.gov.pl
Fax: +48 224587800

Internet address: http://www.uzp.gov.pl

VI.5) Date of dispatch of this notice:
27/09/2017
30/09/2017 S188 - - Supplies - Contract notice - Open procedure

Poland-Nowy S?cz: Antineoplastic and immunomodulating agents

2017/S 188-384622

Contract notice

Supplies

Directive 2014/24/EU

Section I: Contracting authority

I.1) Name and addresses
Szpital Specjalistyczny im. J?drzeja ?niadeckiego
ul. Mly?ska 10
Nowy S?cz
33-300
Poland
Contact person: zespol ds. zamowie? publiczych
Telephone: +48 184436635
E-mail: zamowieniapubliczne@szpitalnowysacz.pl
Fax: +48 184436635
NUTS code: PL218

Internet address(es):

Main address: www.szpitalnowysacz.pl

I.5) Main activity
Health

Section II: Object

II.1) Scope of the procurement
II.1.1) Title:

Dostawa lekow przeciwnowotworowych.

Reference number: DA271-56/17
II.1.2) Main CPV code
33652000
II.1.3) Type of contract
Supplies
II.1.5) Estimated total value
Value excluding VAT: 9 780 786.39 PLN
II.1.6) Information about lots
This contract is divided into lots: yes
II.2) Description
II.2.1) Title:

Leki przeciwnowotworowe

Lot No: 1
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 515 957.49 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Leki przeciwnowotworowe

Lot No: 2
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 461 450.10 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Filgasterim

Lot No: 3
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 2 275.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Leki przeciwnowotworowe

Lot No: 4
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 158 060.25 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Interferon alfa

Lot No: 5
II.2.2) Additional CPV code(s)
33690000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 9 496.20 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Leki przeciwnowotworowe

Lot No: 6
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 1 217 823.56 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Leki przeciwnowotworowe

Lot No: 7
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 392 013.50 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Rituximab

Lot No: 8
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 1 281 590.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Pertuzumab i Trastuzumab

Lot No: 9
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 2 711 451.50 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Olaparyb

Lot No: 10
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 254 664.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Lipegfilgrastym

Lot No: 11
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 36 400.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Leki przeciwnowotworowe

Lot No: 12
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 274 300.20 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Doxorubinum lizosomalna pegylowana

Lot No: 13
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 231 414.40 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Vinorelbin

Lot No: 14
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 5 261.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Temodal

Lot No: 15
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 40 575.60 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Anagrelidum

Lot No: 16
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 237 195.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Lapatinib

Lot No: 17
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 44 121.24 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Bendamustine

Lot No: 18
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 73 387.50 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Cytarabina liposomalna

Lot No: 19
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 54 229.50 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Bortezomib

Lot No: 20
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 76 398.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Lenalidomid

Lot No: 21
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 1 016 569.11 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Abiraterone acetate

Lot No: 22
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 333 850.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Gefitinib

Lot No: 23
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 96 480.00 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Imatinib

Lot No: 24
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 1 706.88 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2) Description
II.2.1) Title:

Afatynib

Lot No: 25
II.2.2) Additional CPV code(s)
33652000
II.2.3) Place of performance
NUTS code: PL218
II.2.6) Estimated value
Value excluding VAT: 206 759.36 PLN
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no

Section IV: Procedure

IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
IV.2.2) Time limit for receipt of tenders or requests to participate
Date: 07/11/2017
Local time: 11:00
IV.2.3) Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4) Languages in which tenders or requests to participate may be submitted:
Polish

Section VI: Complementary information

VI.5) Date of dispatch of this notice:
27/09/2017
TI Title Poland-Nowy S?cz: Antineoplastic and immunomodulating agents
ND Document number 384622-2017
PD Publication date 30/09/2017
OJ OJ S 188
TW Place NOWY S?CZ
AU Authority name Szpital Specjalistyczny im. J?drzeja ?niadeckiego
OL Original language PL
HD Heading - - Supplies - Contract notice - Open procedure
CY Country PL
AA Type of authority 6 - Body governed by public law
HA EU Institution -
DS Document sent 27/09/2017
DT Deadline 07/11/2017
NC Contract 2 - Supplies
PR Procedure 1 - Open procedure
TD Document 3 - Contract notice
RP Regulation 4 - European Union
PC CPV code 33652000 - Antineoplastic and immunomodulating agents
33690000 - Various medicinal products
OC Original CPV code 33652000 - Antineoplastic and immunomodulating agents
33690000 - Various medicinal products
RC NUTS code PL218
IA Internet address (URL) www.szpitalnowysacz.pl
DI Directive Public procurement Directive 2014/24/EU

TRY FOR FREE

Not a USAOPPS Member Yet?

Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.

Start Free Trial Today >